Increased cell proliferation, which is also a common characteristic of a perturbed cell cycle in cancerous cells, requires a general increase in protein synthesis that is, in many cases, sustained also by up-regulation of the ribosome biogenesis rate.
Inactivation of Rb, as appears to be the case in the T-98-G cell lines, can induce quiescent cells to re-enter the cell cycle, initiating cancerous growth.
Numerous studies have shown that Akt, ERK, and JNK signaling pathways have important roles in cancerous cell proliferation, cell cycle, and apoptosis regulation in a p53-dependent or -independent manner [ 22- 24].
PHD3 transcript levels were shown to be increased in HNSCC, and in vitro analysis revealed inhibition of cell cycle progression in cancerous cells in the absence of PHD3 activity [ 45].
The ΔCt values between normal and cancerous group showed a 1.07 cycle difference (ΔΔCt) (p < 0.01) as shown in Table 2. mtDNA content was compared with various clinical and pathological parameters of breast cancer patients such as age, menopause, TNM stage, lymph node status, ER-, PR- and Her-2/neu expression (Table 1).
Tumor suppressors restrict the proliferation of abnormal or cancerous cells by regulating cell-cycle arrest, senescence or apoptosis to prevent the development of cancer.
Furthermore, EGCG may stimulate apoptosis in cancerous cells by negatively regulating the cell cycle to prevent continued division.
In this model, when p27 is active, the cell cycle can be stopped in cancerous situations.
For the cDNA panels, fold-change in mRNA expression was calculated by comparing normalized threshold cycle numbers (CT) in the cancerous tissue compared to the normal tissues.
The p73 protein is a homolog of p53, and has antitumor effects in various cancerous cells, which are mediated through cell cycle arrest and the induction of pro-apoptotic target genes [ 15].
